A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients
Launched by UNIVERSITY OF UTAH · Aug 15, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new home-based program called "The Boost Box" that aims to help people with bladder cancer improve their health before and after surgery. The program includes easy-to-follow diet and exercise plans to support patients who are undergoing cystectomy surgery, which is a procedure to remove the bladder. The goal is to see if this program can help reduce complications, improve nutrition, maintain weight, and enhance the quality of life for patients.
To participate, patients need to be at least 18 years old, newly diagnosed with bladder cancer, and scheduled for surgery at the Huntsman Cancer Institute. Participants will take part in diet consultations, fill out questionnaires, receive weekly Boost Boxes with nutritional support, and track their exercise at home. They will also be compensated for their involvement. The study will compare the outcomes of those following the Boost Box program to a group receiving usual care to see how effective the intervention is.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patients 18 years or older.
- • 2. Newly diagnosed urinary bladder cancer patients indicated for cystectomy with or without neo-adjuvant therapy; Treated with surgery at the Huntsman Cancer Institute
- • 3. Have reliable, consistence access to the internet for study procedures
- • Inclusion of Individuals across the Lifespan: The proposed trial will enroll 20 adults who have been diagnosed with bladder cancer. The age range of participants to be recruited is 18 years or older. Bladder cancer is generally a disease of older age and is exceedingly rare in children. According to the American Cancer Society, average age at diagnosis is 73.1 Therefore, we are unable to include children in this trial.
- • Inclusion of Women, Minorities, and Children: It is anticipated that 20% will be female; 80% male. Racial distribution is projected to be as follows: 97% white, 1% Native Hawaiian or Pacific Islander; 1% American Indian/ Alaska Native; 1% Asian; \<1% Black. Approximately 96% will be Non-Hispanic.
- Exclusion Criteria:
- • 1. Special dietary requirements (i.e., allergies and intolerances, or other clinically prescribed diet).
- • 2. Unable to provide informed consent or read, write, or fill in questionnaires in English
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Mary C Playdon, PhD, MPH
Principal Investigator
University of Utah NUIP Department and Huntsman Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported